|
|
||||||||
1From the Departments of Ophthalmology and 2Corneal Tissue Regeneration, University of Tokyo Graduate School of Medicine, Tokyo, Japan; the 3Nippi Research Institute of Biomatrix, Tokyo, Japan; and the 4Miyata Eye Hospital, Miyakonojo, Japan.
| Abstract |
|---|
|
|
|---|
METHODS. Adult human donor cornea derived from cultured HCECs was labeled with the fluorescent tracker DiI (1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate) and seeded on a collagen sheet. The pump function of the HCEC sheet was evaluated by measurement of the potential difference and short-circuit current. A 6-mm sclerocorneal incision and Descemetorhexis were performed on rabbit eyes. The HCECs on a collagen sheet was brought into the anterior chamber and fixed to the posterior stroma (HCEC group). Rabbit corneas with collagen sheet transplantation after Descemetorhexis (collagen group) and with only Descemetorhexis (no-transplantation group) were the control. Each group, observed for 28 days after surgery, underwent histologic and fluorescence microscopic examinations.
RESULTS. Pump function parameters of the HCEC sheets were 76% to 95% of those of human donor corneas. Mean corneal thickness in the HCEC group was significantly less than in the collagen and no-transplantation groups 1, 3, 7, 14, 21, and 28 days (P < 0.05) after surgery. DiI-labeled cells were spread over the rear corneal surface in the HCEC group. Marked stromal edema was present in the collagen and no-transplantation groups with hematoxylin-eosin staining, but none in the HCEC group with collagen sheets bearing monolayer cells.
CONCLUSIONS. The findings indicate that cultured HCECs transplanted from adult human donor cornea by means of a collagen sheet can retain their function of corneal dehydration in a rabbit model and suggest the feasibility of transplantation for CEC dysfunction using cultured HCECs with a collagen sheet.
A culture technique for HCECs derived from adult human donor corneas recently was established, and transplantation onto denuded Descemets membrane of cultured HCECs ex vivo provided morphologic findings.11 12 13 14 15 16 We evaluated the function of cultured HCECs derived from adult human donor cornea in an in vivo rabbit model and propose a cultured HCEC transplantation method that uses a collagen sheet as a substitute carrier of HCECs.
| Materials and Methods |
|---|
|
|
|---|
Primary Culture of HCECs
Primary HCEC cultures were made as described elsewhere.16 Briefly, cultures were established from the remainder of donor corneas after full-thickness corneal transplantation. All the donor corneas were obtained from the Rocky Mountain Lions Eye Bank. Small explants from the endothelial layer, including Descemets membrane, were removed with sterile surgical forceps. The approximately 0.5-mm2 explants were made of a cornea and placed endothelial cell-side down onto four 35-mm tissue culture dishes coated with bovine ECM and the dishes carefully placed in an incubator. This coating dish was prepared by primary bovine CEC culture and CEC removal with trypsin-EDTA, because the ECM derived from bovine CECs is essential for primary culture of HCECs.16 The medium was exchanged after 3 days and thereafter replaced every other day. When a sufficient proliferating cell density was reached, the HCECs were passaged at ratios ranging from 1:1 to 1:4. Subsequent passages were done by the same method, but at a ratio of 1:16. Cultured cells from the fourth and fifth passages were used in the study.
Seeding of Cultured HCECs on Collagen Sheets
The cell carriers were collagen sheets obtained from Nippi Research Institute of Biomatrix (Tokyo, Japan). Each sheet, composed of a network of loosely cross-linked type I collagen, was treated with alkaline solution, dried, and sterilized for 2 hours under ultraviolet light, as reported previously.17 18 Before use, the desiccated sheets were immersed for 10 minutes in sterilized saline. A 6.0-mm trephine was used as the biopsy punch (Kai Medical, Gifu, Japan). Each sheet was approximately 40 to 50 µm thick. To observe HCEC localization after transplantation, cultured HCECs were labeled with the fluorescent tracker DiI 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; Cell tracker CM-DiI, C-7000; Molecular Probes, Eugene, OR) before reconstruction. Immediately before labeling, DiI was diluted to 10 µg/mL with phosphate-buffered saline (PBS). Trypsinized 1.0 x 106 HCECs were incubated in 5 mL DiI solution on ice for 5 minutes at 37°C and then for an additional 15 minutes at 4°C. After labeling, the HCECs were washed twice with PBS and resuspended in 300 µL low-glucose DMEM containing 6% dextran (Amersham Pharmacia Biotech AB, Uppsala, Sweden).
An HCEC suspension of 1.0 x 106 cells in 300 µL culture medium was transferred to each sheet, and the sheet placed in individual wells of 96-well plates. The plates then were centrifuged at 1000 rpm (176g) for 10 minutes to enhance cell attachment to the sheets. Sheets were maintained in the cell culture medium for 2 days, after which nonadhering cells and debris were removed.
Measurement of the Pump Function of the HCEC Collagen Sheet
Pump functions of four HCEC collagen sheets were measured, with some modification, in a Ussing chamber as reported previously.19 20 21 Six relaxing radial incisions were made in the peripheral area of donor corneas from which epithelium had been scraped mechanically. The donor corneas (n = 4), collagen sheets only (n = 4), and HCEC collagen sheets (n = 4) were mounted in the Ussing chamber. Corneas were incubated in Ringer solution containing (in mM): NaCl, 117.5; NaHCO2, 24; KCl, 4; Na2HPO4, 1; MgSO4, 1; glucose, 4.45; reduced glutathione, 1; and CaCl2, 2.54 and bubbled with a 5% CO27% O2, 88% N2 gas mixture to pH 7.38. After steady state levels of the potential difference and short-circuit current were reached, ouabain (0.1 mM), an Na+,K+-ATPase inhibitor, was added to the chamber, and the potential difference and short-circuit current redetermined.
Transplantation of Cultured HCECs into Rabbits
Treatment was in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. All the rabbits were from Saitama Experimental Animals, Inc. (Saitama, Japan). Eight New Zealand White rabbits, weighing 2.0 to 2.4 kg, were anesthetized intramuscularly with ketamine hydrochloride (60 mg/kg; Sankyo, Tokyo, Japan) and xylazine (10 mg/kg, Bayer, Munich, Germany). After disinfection and sterile draping of the operation site, a 6-mm sclerocorneal incision centered at 12 oclock was made with a slit knife (Alcon Surgical, Tokyo, Japan), and a viscoelastic agent (Healon; Amersham Pharmacia Biotech AB) was infused into the anterior chamber (Fig. 1A) . After the corneal surface had been ruled with a marking pen (Devon Industries Inc, Madrid, Spain), a 6.0-mm diameter circular Descemetorhexis was created in the center of the cornea with a 30-gauge needle (Terumo, Tokyo, Japan) (Fig. 1B) , and Descemets membrane was removed from the anterior chamber of the eye (Fig. 1C) . A reconstructed HCEC sheet or collagen sheet without HCECs was put on human plasma fibronectin (100 µg/100 µL; Invitrogen-Gibco) for 8 to 10 minutes before transplantation. Then the collagen sheets coated with 40 µL fibronectin (1 µg/µL) was brought into the anterior chamber and attached and fixed to the posterior stroma stripped of Descemets membrane (Fig. 1D) . For HCEC sheet transplantation, the sheet with the HCEC side up was put on a foldable silicone plate (Fig. 1E) . After the HCEC surface was coated with an ophthalmic viscosurgical device, the silicone plate was folded by forceps, HCEC side in, and inserted into the anterior chamber. Then, only the silicone plate on the HCEC sheet was removed from the anterior chamber. Adhesion of the reconstructed HCEC sheet or collagen sheet to the recipient stroma was confirmed after the anterior chamber was washed with PBS three times. If the HCEC sheet was difficult to attach, an air bubble was injected into the anterior chamber. The sclerocorneal wound was closed with two to three interrupted 10-0 nylon sutures (Mani, Tochigi, Japan), and ofloxacin ophthalmic ointment (Santen, Osaka, Japan) was instilled immediately after.
|
Clinical Observations
Each surgically treated eye was checked daily by external examination with a slit lamp biomicroscope and photographed 7, 14, and 28 days after surgery. Central corneal thickness was measured with an ultrasound pachymeter (Tomey, Nagoya, Japan), and intraocular pressure with a pneumatic tonometer (model 30 Classic; Mentor, Norwell, MA) 1, 3, 7, 14, 21, and 28 days after surgery. An average of three readings was taken.
Histologic Examination and Localization of HCECs
One month after transplantation, the rabbits, under deep anesthesia, were killed by an intravenous overdose of pentobarbital sodium (Dainippon Pharmaceutical, Osaka, Japan). Their corneas were excised and bisected. HCEC morphology was evaluated on one side of the divided corneas. All the plates were examined under a light microscope (model BX-50; Olympus, Tokyo, Japan) and the images saved to a computer. The number of cells in a 0.1-mm2 area was counted at four different sites in the four reconstructed corneas. Wholemount samples of the corneas of the HCEC group also were examined for DiI-labeled HCEC fluorescence under a fluorescence microscope (models BH2-RFL-T3 and BX50; Olympus, Tokyo, Japan) at an excitation wavelength of 420 nm and an emission wavelength of 480 nm. The other half of the divided cornea was removed immediately, fixed in 10% formalin (Wako Pure Chemicals, Osaka, Japan), and used for hematoxylin and eosin (HE) staining.
Statistics
The Kruskal-Wallis analysis of variance and the Dunn post hoc procedure were used to compare the corneal thickness among the three groups. The level of significance was set at P < 0.05.
| Results |
|---|
|
|
|---|
|
Clinical Observations after Surgery
Corneal edema decreased much earlier after HCEC sheet transplantation in the HCECs than in the collagen and no-transplantation groups. In the collagen and no-transplantation control group groups, mean corneal thickness was approximately 1000 µm throughout the 28 days of observation. In contrast, it decreased rapidly in the HCEC group, being significantly less than in the control group 1 (P < 0.05), 3, 7, 14, 21, and 28 days (P < 0.001) after surgery (Fig. 3) . Figure 4 shows representative anterior segment photographs for each group. Compared with the opaque cornea with severe stromal edema seen in the collagen and no-transplantation groups, in the HCEC group on day 28, the reconstructed cornea transplanted by means of a cultured HCEC sheet was clear with no stromal edema (Fig. 4) . In the slit lamp examination, mild stromal opacity was discernible on the layer attached to the collagen sheet. There was no intraocular pressure increase in each group throughout the observation period (data not shown).
|
|
|
|
| Discussion |
|---|
|
|
|---|
To make up for the inadequate supply of donor corneas, studies have shown the feasibility of using cultured animal CECs as transplants in in vivo animal models.1 2 3 4 5 6 7 This type of transplantation, however, has yet to be achieved clinically because of difficulties in culturing HCECs from adult human donor corneas and the lack of thin, transparent HCEC carriers. We found that the potential difference and short-circuit current of a cultured HCEC collagen sheet are similar to those of donor corneas, indicative that the pump function, which depends mainly on Na+,K+-ATPase,and does not work completely, is satisfactory in reconstructed HCEC sheets. Rabbit corneas receiving cultured HCEC collagen sheets showed decreased corneal edema, whereas severe stromal edema was present throughout the follow-up period in corneas without cultured HCEC sheets. Results are supported by histologic examinations of corneas, with and without cultured HCECs. These findings and the residual DiI-labeled cells derived from HCECs indicate that transplantation of the cultured HCECs contributes to the maintenance of corneal stromal hydration, evidence of the feasibility of using this type of transplantation as a substitute carrier of HCECs.
Histologic examinations showed fibroblast-like cells at the stroma attached to the HCEC collagen sheets. These cells were induced by the collagen sheets with fibronectin as the adhesive, not by the cultured HCECs, as seen in similar histologic findings for the transplantation of collagen sheets without HCECs (collagen group). Because the HCEC sheet produced only mild opacity of the posterior stromal layer attached to the collagen sheet in the slit lamp microscope examination and no immunosuppressive agents had been administered during the follow-up period, topical immunosuppressants such as corticosteroid eye drops may easily prevent fibroblast-like cell infiltration. However, long-term follow-up studies are needed.
It is worth commenting on the immunologic rejection of human-to-rabbit xenotransplantation that occurs in this model. In the full-thickness murine corneal xenotransplantation model, no hyperacute rejection occurs, but corneal xenografts are rejected in concordant or discordant combination without exception, on the average over a period of 2 to 16 days after transplantation.25 26 27 28 In our study, no apparent inflammatory reactions, such as massive cell infiltration, keratic precipitates, or fibrin formation were present in the anterior chamber of rabbit eye under slit lamp microscopy, evidence that there was no notable episode of acute immunologic rejection. The anterior chamber of the eye is an immune-privileged site and anterior chamber-associated immune deviation (ACAID) permits the long-term acceptance and survival of histoincompatible tissue grafts that otherwise are rejected when transplanted to various anatomic sites.29 30 In HCEC sheet transplantation, the transplanted HCECs, which face the anterior chamber, may induce ACAID, thereby avoiding immunologic rejection, the leading cause of graft failure in full-thickness corneal transplantation. Another possible reason is due to the character of the collagen sheet, which does not permit cell infiltration. As shown in representative HE staining of the HCEC group, there were no infiltrating cells in the collagen sheet itself. No infiltrating cells were detected in the collagen sheet separated in 10% formalin for fixation in the collagen group (data not shown). These findings suggest that antigen-presenting cells derived from the recipient can recognize xenoantigens only through aqueous humor, but not corneal stroma. Therefore, xenoantigens may fail to sensitize fully the recipients secondary lymphoid tissue to induce immunologic rejection during the observation period. However, we cannot completely deny the possibility of mild subclinical immunologic rejection, because postoperative endothelial densities on an HCEC sheet decreased compared with preoperative densities.
In summary, using anterior chamber insertion of a collagen sheet bearing HCECs, we developed a transplantation technique that uses a collagen sheet as the substitute carrier of HCECs. We conclude that cultured HCECs derived from adult human donor corneas retain the essential CEC function of dehydration of the corneal stroma in vivo; an artificial collagen sheet can serve as the carrier of HCECs; and anterior chamber insertion of an HCEC collagen sheet with fine forceps does not require a corneal full-thickness trephination and corneal button sutures. Our findings indicate that transplantation of cultured HCECs by means of a collagen sheet can retain their function of corneal dehydration in a rabbit model.
| Footnotes |
|---|
Submitted for publication October 24, 2003; revised March 24 and May 2, 2004; accepted June 3, 2004.
Disclosure: T. Mimura, None; S. Yamagami, None; S. Yokoo, None; T. Usui, None; K. Tanaka, None; S. Hattori, None; S. Irie, None; K. Miyata, None; M. Araie, None; S. Amano, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Satoru Yamagami, Department of Corneal Tissue Regeneration, Tokyo University Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo, Japan 113-8655; syamagami-tky{at}umin.ac.jp.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y.-T. Zhu, Y. Hayashida, A. Kheirkhah, H. He, S.-Y. Chen, and S. C. G. Tseng Characterization and Comparison of Intercellular Adherent Junctions Expressed by Human Corneal Endothelial Cells In Vivo and In Vitro Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3879 - 3886. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakai, O. Fainaru, L. Bazinet, P. Pakneshan, O. Benny, E. Pravda, J. Folkman, and R. J. D'Amato Dendritic Cells Augment Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3666 - 3670. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koizumi, Y. Sakamoto, N. Okumura, N. Okahara, H. Tsuchiya, R. Torii, L. J. Cooper, Y. Ban, H. Tanioka, and S. Kinoshita Cultivated Corneal Endothelial Cell Sheet Transplantation in a Primate Model Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4519 - 4526. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Suh, C. Zhang, R. S. Chuck, W. J. Stark, S. Naylor, K. Binley, S. Chakravarti, and A. S. Jun Cryopreservation and Lentiviral-Mediated Genetic Modification of Human Primary Cultured Corneal Endothelial Cells Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3056 - 3061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Lai, K.-H. Chen, W.-M. Hsu, G.-H. Hsiue, and Y.-H. Lee Bioengineered Human Corneal Endothelium for Transplantation Arch Ophthalmol, October 1, 2006; 124(10): 1441 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mimura, S. Yokoo, M. Araie, S. Amano, and S. Yamagami Treatment of Rabbit Bullous Keratopathy with Precursors Derived from Cultured Human Corneal Endothelium Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3637 - 3644. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mimura, S. Yamagami, S. Yokoo, M. Araie, and S. Amano Comparison of Rabbit Corneal Endothelial Cell Precursors in the Central and Peripheral Cornea Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3645 - 3648. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mimura, S. Yamagami, S. Yokoo, Y. Yanagi, T. Usui, K. Ono, M. Araie, and S. Amano Sphere Therapy for Corneal Endothelium Deficiency in a Rabbit Model Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3128 - 3135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yokoo, S. Yamagami, Y. Yanagi, S. Uchida, T. Mimura, T. Usui, and S. Amano Human Corneal Endothelial Cell Precursors Isolated by Sphere-Forming Assay Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1626 - 1631. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |